Repaglinide

Product Name:Repaglinide; (S)-[A-(2-methylpropyl)-2-(1-piperidinyl)benzene-methanamine; (s)-3-methyl-1-(2-piperidineophenyl)-1-butylamine; (S)-3-Methyl-1-[2-(1-piperidinyl) phenyl]butylamine; (s)-3-methyl-1-(2-piperidin-1-ylphenyl)butylamine; (S)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine n-acetyl-glutamate; (S)-3-methyl-1-(2-piperidin-1-yl-phenyl)butylamine; (1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine; (S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine

CAS No:147769-93-5 M F: C16H26N2 MW: 246.39 Product Categories: Pharmaceutical material and intermeidates Mol File: 147769-93-5.mol

Chemical and Physical Properties: Density:0.99 g/cm3 Boiling Point:370.5 °Cat760mmHg Flash Point: 164.724 °C Polarizability: 30.927 10-24cm3 Surface Tension: 39.8 dyne/cm Enthalpy of Vaporization: 61.743 kJ/mol Vapour:0mmHg at 25°C Packaging and storage: Preserve in tight containers.

Repaglinide is an insulin promote the release agent, mainly for non-insulin-dependent diabetes treatment, which contains a chiral carbon atom, S (+) is R (-) 100 times more active configuration efficacy Therefore clinical use S (+) isomer is the active sulfonylurea 18-25 times. The drug is effective, small doses, side effects is low.

(S)-3-Methyl-1-(2-(1-piperidinyl) phenyl)butylamine is the key synthetic Part of the Repaglinide.

Benzenemethanamine, a-(2-methylpropyl)-2-(1-piperidinyl)-,(aS)- , its cas register number 147769-93-5. It also can be called (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine .